Common Chinese herbal medicines fall in overall prices

The price of Chinese herbal medicines is significantly affected by supply and demand. In the second half of the year, a large number of Chinese herbal medicines went on the market, and the market price of Chinese herbal medicines fell back.

The industry believes that the price return is the trend of Chinese herbal medicines <br> <br> Recently, reporters from the market, pharmacies, etc. understand that, the common market of traditional Chinese medicine prices are "a few happy tears": like white technique, due to the large number of new The listing of goods and even the new goods fell in price; and 37 saw a rapid rebound after the holiday season. But overall, the fall in the price of domestic herbal medicines still makes the pharmaceutical companies relieved, and the cost burden is not so heavy.

At present, the number of new products listed by Atractylodes has increased, and the supply of goods has slowed down significantly. The price of Chen’s goods also fell slightly. On the 10th, Chen’s goods were about 18 yuan; the gargle about 15 to 16 yuan was slightly worse; the slightly milder 12 yuan was about 2 yuan less than a week ago.

“Not only Atractylodes macrocephala, but also common Chinese herbal medicines such as Coptis chinensis, Radix et Rhizoma, Radix Astragali, Rhizoma Chuanxiong, etc., prices have declined to different extents. Like Chuanxiong, the market’s better delicacies price is only 13 yuan. The market transaction price is also more than ten dollars." Qingping herbs market, a drug dealer told reporters.

The above-mentioned drug dealers stated that the price of Coptis was lower due to oversupply and excessive inventories; the Beisha ginseng experienced slow growth, increased yields, and increased planting, and local growers actively processed drying conditions, and market prices showed a slow decline.

However, some Chinese herbal medicines have increased in price. In mid-September, the price of March rose steadily, but in the past, there was a “magnificent turn” on March 17. The reporter learned that, as far as the national market is concerned, it has been purchased by pharmaceutical companies and marketers since the recent production. Goods, March and March's move significantly improved, the market quickly rebounded, the current small-scale move in the market in Luzhou has also been improved, countless head price of 620 yuan, 120 price in 630~640 yuan, 80 price of 650 yuan, 60 The head price is almost flat with 80 heads, and the price of 30 heads is around 750 yuan. The specs generally rise about 50 yuan.

Coincidentally, the Codonopsis also ushered in a "small upsurge" in sales after the Festival. "Autumn and Dungeon belong to the multi-purpose season of Codonopsis, which may be one of the main reasons why their prices begin to strengthen." Professor Zhang Shijun, a professor of traditional Chinese medicine at the First Affiliated Hospital of Sun Yat-sen University. It is understood that the market is now containing 65 to 70 yuan in sulfur strips, 75 to 80 yuan in the strip, 90~95 yuan in large strips, 100 yuan in sulfur-free strips, up to 115 to 120 yuan. Due to the large number of new products listed on the Codonopsis still appearing on a certain date, coupled with the fact that the production areas do not reflect a large amount of output, industry insiders expect that the market will remain strong in the future.

Pharmaceutical companies: prices fall to ease cost pressures <br> <br> It is understood that many common kinds of Chinese herbal medicines, especially home prices began to cool down in the second half of this year, and that for many pharmaceutical companies, it can be described as mind hanging A large stone can be temporarily grounded.

A relevant person in charge of Hutchison-Hutchison Hutchison Whampoa Co., Ltd. said that the price of common domestic herbal medicines continues to rise, which will cause some companies to take advantage of genuine and fake speculation, resulting in a decline in product quality and ultimately harm consumers. And excessively high prices of Chinese herbal medicines will bring heavy cost pressures to downstream production companies. Most of the production companies have been at a loss for several consecutive years.

According to a person in charge of the Chinese Medicinal Materials Information Center of the Chinese Medicine Association, the overall return of Chinese herbal medicines prices is a general trend, but the prices of many medicinal herbs have apparently declined or will not appear until 2013.

The reporter learned that in order to control costs and ensure quality, more and more pharmaceutical companies have started to build self-built Chinese herbal medicine planting bases. The listed companies including Yunnan Baiyao, Huashen Group, Tasly, and Baiyunshan have their own Planting bases, and their scale and output are constantly expanding.